AssuredPartners Investment Advisors LLC Invests $256,000 in Axon Enterprise, Inc. (NASDAQ:AXON)

AssuredPartners Investment Advisors LLC purchased a new position in Axon Enterprise, Inc. (NASDAQ:AXON) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 430 shares of the biotechnology company’s stock, valued at approximately $256,000.

A number of other large investors also recently bought and sold shares of the business. Public Sector Pension Investment Board grew its stake in shares of Axon Enterprise by 19.2% in the third quarter. Public Sector Pension Investment Board now owns 3,104 shares of the biotechnology company’s stock worth $1,240,000 after acquiring an additional 500 shares during the last quarter. Friedenthal Financial boosted its stake in Axon Enterprise by 961.7% in the 4th quarter. Friedenthal Financial now owns 1,359 shares of the biotechnology company’s stock worth $808,000 after purchasing an additional 1,231 shares in the last quarter. Principal Financial Group Inc. grew its position in Axon Enterprise by 33.1% during the 3rd quarter. Principal Financial Group Inc. now owns 136,302 shares of the biotechnology company’s stock valued at $54,466,000 after purchasing an additional 33,869 shares during the last quarter. XTX Topco Ltd increased its stake in Axon Enterprise by 20.6% during the 3rd quarter. XTX Topco Ltd now owns 5,650 shares of the biotechnology company’s stock valued at $2,258,000 after purchasing an additional 964 shares in the last quarter. Finally, Artemis Investment Management LLP raised its holdings in Axon Enterprise by 21.4% in the fourth quarter. Artemis Investment Management LLP now owns 95,113 shares of the biotechnology company’s stock worth $56,528,000 after buying an additional 16,792 shares during the last quarter. 79.08% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on the stock. Robert W. Baird raised their price target on shares of Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a research report on Friday, December 6th. Morgan Stanley raised Axon Enterprise from an “equal weight” rating to an “overweight” rating and lifted their target price for the stock from $500.00 to $700.00 in a report on Tuesday, December 3rd. TD Cowen started coverage on Axon Enterprise in a report on Wednesday, January 8th. They set a “buy” rating and a $700.00 price target on the stock. Northcoast Research downgraded Axon Enterprise from a “buy” rating to a “neutral” rating in a report on Wednesday, February 19th. Finally, Barclays restated a “hold” rating on shares of Axon Enterprise in a research note on Monday, March 10th. One research analyst has rated the stock with a sell rating, two have issued a hold rating and eleven have given a buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $604.67.

Axon Enterprise Trading Down 2.9 %

NASDAQ:AXON opened at $534.95 on Friday. Axon Enterprise, Inc. has a one year low of $273.52 and a one year high of $715.99. The business has a fifty day moving average price of $589.62 and a 200-day moving average price of $547.97. The firm has a market capitalization of $40.99 billion, a price-to-earnings ratio of 138.23, a price-to-earnings-growth ratio of 5.17 and a beta of 1.12. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63.

Insider Transactions at Axon Enterprise

In other news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the firm’s stock in a transaction on Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total transaction of $271,831.50. Following the sale, the director now directly owns 6,929 shares in the company, valued at $4,185,601.03. This trade represents a 6.10 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Jeri Williams sold 307 shares of the company’s stock in a transaction on Monday, March 17th. The stock was sold at an average price of $552.72, for a total transaction of $169,685.04. Following the completion of the transaction, the director now directly owns 1,627 shares of the company’s stock, valued at $899,275.44. This represents a 15.87 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 6.10% of the company’s stock.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.